Clinical Trials Logo

Cerebral Vascular Disorder clinical trials

View clinical trials related to Cerebral Vascular Disorder.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04265664 Completed - Stroke Clinical Trials

Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke

TRAIL
Start date: July 28, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the feasibility and effectiveness of a lower extremity telerehabilitation protocol with aims to improve lower extremity recovery among community-living stroke survivors across Canada.

NCT ID: NCT03689387 Completed - Clinical trials for Cerebral Vascular Disorder

Evaluation of Physical Activity Practice (AP) After Cerebral Vascular Stroke (Stroke)

QAP-AVC
Start date: October 23, 2017
Phase:
Study type: Observational

Physical activity is defined by any movement produced by the skeletal muscles responsible for an increase in energy expenditure. The Stroke Council of the American Heart Association (AHA) recommends, in prevention after the occurrence of a first stroke, the practice of moderate to intense physical activity for 40 minutes a day, three to four times a week (Lackland et al., 2014). The World Health Organization (WHO) also recommends the practice of at least 150 minutes of moderate-intensity endurance activity or at least 75 minutes of endurance activity of sustained intensity per week, adapted to the possibilities of the patient (World Health Organization 2010). Unfortunately, the majority of stroke patients have activity below recommendation (Rand et al., 2009). The main hypothesis of this work is that the amount of AP, measured by self-questionnaire, is insufficient, and below current recommendations in patients with stroke, after return home. Given the multiple physical, psychological, social, and economic benefits of PA practice, it is also important to identify the habits and challenges that patients experience with PA, so that they can be better informed. advise and guide them to reach AP stroke recommendations.

NCT ID: NCT03209258 Completed - Stroke Clinical Trials

The Third, Intensive Care Bundle With Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial

INTERACT3
Start date: December 12, 2017
Phase: N/A
Study type: Interventional

Continued uncertainty exists over benefits of early intensive blood pressure (BP) lowering in acute intracerebral hemorrhage (ICH), related to the non-significant primary outcomes, patient selection, and discordant results of INTERACT2 and ATACH-II. We designed INTERACT3 to determine the effectiveness of a goal-directed care bundle of active management (intensive BP lowering, glycemic control, treatment of pyrexia and reversal of anticoagulation) vs. usual care in ICH. INTERACT3 is a large-scale pragmatic clinical trial to provide reliable evidence over the effectiveness of a widely applicable goal-directed care bundle in acute ICH.

NCT ID: NCT03043092 Completed - Clinical trials for Cerebral Vascular Disorder

Transcranial Doppler Ultrasound in Critically Ill Patients With Cardiovascular Comorbidities

CRITIDOP
Start date: June 14, 2016
Phase:
Study type: Observational

Transcranial Doppler ultrasound is bedside tool use to assess cerebral blood perfusion in critically ill patients. We sought to conduct a prospective, single centre study aiming to determine whether chronic vascular diseases may be a confounder in transcranial Doppler ultrasound assessment in critically ill patients.